Ampio Pharmaceuticals, Inc.
Ampio Pharmaceuticals, Inc. (AMPE) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 92 transactions totaling $763.4K, demonstrating a bearish sentiment with -$496.8K in net insider flow. The most recent transaction on Jun 9, 2023 involved a purchase of 21,858 shares valued at $6.3K.
AMPE Insider Activity Summary
Who Is Buying AMPE Stock?
No significant insider buying has been recorded for AMPE in the recent period.
Who Is Selling AMPE Stock?
No significant insider selling has been recorded for AMPE in the recent period.
Is Ampio Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AMPE is bearish with an Insider Alignment Score of 17/100 and a net flow of -$496.8K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AMPE Frequently Asked Questions
Understanding AMPE Insider Activity
Insider trading at Ampio Pharmaceuticals, Inc. (AMPE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading AMPE stock, having executed 92 transactions in the past 90 days. The most active insider is Vaughan Lennox Clift (Executive), who has made 1 transactions totaling $4.2M.
Related Tools
Track Ampio Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at AMPE file new Form 4 transactions